0,00 €
0
🔥 Metabolic & Fat Loss

Semaglutide

GLP-1 receptor agonist · long-acting GLP-1 agonist

A long-acting GLP-1 receptor agonist researched extensively for its effects on glucose regulation and appetite signalling.

Type
GLP-1 receptor agonist
Common sizes
20 mg
Research focus
GLP-1 signalling
Often studied with
Tirzepatide · Cagrilintide
🧬

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist engineered for an extended half-life through structural modifications. Research examines its stimulation of glucose-dependent insulin signalling, its influence on gastric emptying and appetite pathways, and its role as a widely referenced single-receptor incretin compound in metabolic models.

It is one of the most studied GLP-1 analogs. It is used strictly as a research reagent.

🔬

Areas of research

🎯

GLP-1 agonism

Studied for selective activation of the GLP-1 receptor in metabolic model systems.

🩸

Insulin signalling

Researched for glucose-dependent insulin secretion effects in preclinical models.

🍽️

Appetite & satiety

Examined for influence on appetite, satiety, and gastric-emptying pathways.

⏱️

Extended half-life

Investigated for structural modifications giving prolonged receptor activity.

💧

In the lab: reconstitution

1

Bring the vial (20 mg) and bacteriostatic water to room temperature.

2

Add bacteriostatic water slowly along the glass wall — the volume you add sets the concentration.

3

Swirl gently (do not shake) until fully clear, then refrigerate at 2–8 °C.

Tip: The Peptide Calculator converts any vial size and water volume into units per syringe mark automatically.

Full storage & handling guide →

🧩

Commonly researched combinations

🔗

Semaglutide + Cagrilintide

Studied together to model GLP-1 agonism alongside amylin-receptor appetite signalling.

View stack →
📊

Semaglutide + Tirzepatide

Compared in research contrasting single- versus dual-receptor incretin mechanisms.

View stack →
📚

Selected research studies

Semaglutide — semaglutide GLP-1 receptor agonistPubMed ↗
Semaglutide — semaglutide appetite glucosePubMed ↗
Semaglutide — GLP-1 analog metabolic signalingPubMed ↗

Links open a PubMed search for the topic. They point to independent literature and are provided for orientation in a research context only.

💬

FAQ

What is Semaglutide?

It is a long-acting GLP-1 receptor agonist researched for effects on glucose-dependent insulin signalling and appetite pathways, engineered for an extended half-life and widely used as a reference incretin compound in metabolic studies.

Why is its half-life notable?

Structural modifications give Semaglutide prolonged receptor activity, which research studies for its influence on sustained GLP-1 signalling in metabolic model systems.

How is it used here?

It is handled as a research reagent for laboratory and preclinical metabolic studies of GLP-1 signalling, with no approved clinical or therapeutic use in this context.

Explore Semaglutide

See the product, or build a stack around it.

View product →Open Stack-Builder →
For laboratory research only. This guide is provided solely for scientific orientation. Semaglutide and all products are not intended for human or animal use, nor for the diagnosis, treatment or prevention of any disease. Nothing here is dosing guidance.
© Nephiz Labs · Peptide Guide: Semaglutide
Research-use information
Shop
Search
Account
Cart
0
Your Cart (0)
Empty CartYour cart is emptyReturn to Shop
Secure Checkout Secure Checkout
Premium Quality Premium Quality
Fast Shipping Fast Shipping